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ABSTRACT
Objective: To verify the association between the profile of women who seek specialized 
treatment for the use of psychoactive substances, their treatment adherence time and the 
types of substance used. Method: A retrospective cohort with data from medical records 
of women who sought care at a referral service for the use of psychoactive substances. 
Results: The final sample consisted of 411 medical records. A significant association 
was observed between unemployment (p<0.000), living in the streets/homeless 
shelters (p=0.003), having HIV/AIDS (p=0.004) and the type of substance used. The 
best predictors for the treatment adherence time were being a cocaine and crack user 
(OR=0.22), having family members who use illegal substances (OR=0.36) and reporting 
suicidal ideation (OR=2.7). Conclusion: The sociodemographic and epidemiological 
factors of the women in this study are associated with the use of psychoactive substances. 
The therapeutic strategies developed for this group should take into account the risk 
stratification, seeking comprehensive and individualized care. Persistent approaches to 
include family members in the treatment, especially of those who present problems 
related to the use of psychoactive substances should be considered.
DESCRIPTORS
Women; Substance-Related Disorders; Mental Health Services; Substance Abuse 
Treatment Centers; Psychiatric Nursing.
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INTRODUCTION
The consequences of using psychoactive substances 
for users and for society are the study objective in several 
knowledge areas. It is also considered a public health 
problem(1-2), since the abusive use of these substances is 
associated to the development of several health problems 
such as substance use disorders (SUD), the development 
of neuropsychiatric and gastrointestinal disorders, cancers, 
and increased possibilities of sexually transmitted infec-
tions (STIs)(2-4). 
The prevalence of alcohol use in the Brazilian popula-
tion is higher among men than among women, 62% and 
38% respectively(5), a phenomenon that is also observed 
in other countries(6-7). Although men in Brazil have a 
higher prevalence of alcohol consumption, the percentiles 
of substance use disorders have declined among them, 
while those of women have increased between 2006 and 
2012(5-6).
Data from the World Health Organization(8) have 
indicated that the use of illicit drugs is higher among 
men, while the use of tranquilizers and sedatives is more 
prevalent among women. Although the percentage of men 
with illicit drug-related disorders is higher than that of 
the female population, there is evidence in the literature 
of an increase in this number among women(5-7,9).
Women who use psychoactive substances have pecu-
liarities, and the services that provide treatment to this 
clientele must be attentive to these characteristics in 
order to meet the real needs of this population(9). The 
epidemiological conceptions presented previously should 
be taken into account for the treatment(10), and aspects 
such as support from family members/friends, prospects 
of improvement, accessibility, gratuity, having a higher 
income, having a job, and having preserved mental and 
physical health are related to longer treatment adher-
ence and better treatment outcomes(11). In addition, 
women who consume alcohol tend to adhere to treat-
ment longer when compared to women who consume 
other substances(12).
Considering the importance of investigating these 
characteristics in a specialized service in the Brazilian 
reality, and taking into account that the findings may 
contribute to developing strategies for care of female 
users of psychoactive substances, this study aims to verify 
the association between the profile of women who seek 
specialized treatment for the use of psychoactive sub-
stances, their treatment adherence time and the types of 
substances used.
METHOD
Study deSign
This is a retrospective cohort study. The study was con-
ducted using data from medical records of a specialized 
treatment service for psychoactive substance use disorders 
in the city of São Paulo – SP.
data collection
Data were collected in 2011. Self-reported question-
naires presented in the medical records of women who 
sought voluntary treatment for the use of psychoactive 
substances between January 2002 and December 2010 
were analyzed. This period was chosen because it rep-
resents a transition phase from an outpatient model to 
an open care model, which met the guidelines of the 
Psychiatric Reform and the characteristics of the popula-
tion present in the territory. 
All medical records within the established period 
were initially included (N=1,678), however those which 
corresponded to women who only sought treatment for 
smoking and/or obesity and the records that presented 
more than 25% of missing data were excluded (N=1,267). 
Thus, the final sample consisted of 411 medical records. 
The questionnaire for anamnesis of the medical records 
was composed of questions regarding the cohort’s char-
acteristics. Sociodemographic characteristics were: age, 
birthplace, education level, occupation, marital status, 
religion, how they came into contact with the treatment, 
type of housing, whether they suffered violence in child-
hood, whether they suffered violence in their adolescence, 
whether they suffered losses in childhood, whether they 
suffered losses in adolescence, age of first sexual intercourse, 
first drug used, age of first contact with alcohol, age of first 
contact with tobacco, and any legal/criminal problems. 
The clinical characteristics were: hypertension, having 
HIV/AIDS and the presence of suicidal ideation; while 
the behavioral characteristics were: having family members 
who are users of psychoactive substances, the type of psy-
choactive substance used by the family member(s), and for 
which type of psychoactive substance the woman sought 
treatment for. Information regarding the treatment adher-
ence time was determined according to the date of the first 
and last entries in the medical record, and were collected 
and divided into five categories: 1 day, up to 1 month, 1 to 
6 months, 6 to 12 months and more than 1 year.
data analySiS
A descriptive data analysis was performed to identify 
the sample profile, the categorical variables were pre-
sented as absolute and relative frequencies, and numeri-
cal variables as central tendency measurements (mean, 
standard deviation and median). For the analysis, the type 
of psychoactive substance for which the woman sought 
treatment for was divided into three categories: alcohol 
use (A), use of multiple drugs excluding cocaine and crack 
(MDE), and use of multiple drugs including cocaine and 
crack (MDI). The choice for this division was decided 
based on the hypothesis that women who use cocaine 
and crack have different associations, such as adhering 
to treatment for shorter periods of time.
The Chi-square test and analysis of variance (ANOVA) 
were used to verify the association between sociodemo-
graphic, clinical and behavioral characteristics of the par-
ticipants and which type of psychoactive substances they 
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sought treatment for. A logistic regression analysis was 
performed with prior exploration using the chi-square 
test in order to verify the association between the treat-
ment adherence time and the participants’ profiles. All 
tests were performed using “R” software, considering a 
significance value of p ≤ 0.05.
ethical aSpectS
The research was performed according to the recom-
mendations of Resolution no. 196/96, revised and updated 
by Resolution no. 466/2012 of the National Health 
Council for research involving human beings in Brazil, 
and was duly approved by the Research Ethics Committee 
(CEP) of the School of Nursing of the Universidade de 
São Paulo under opinion number 74371/2012. 
RESULTS
The sociodemographic profile of the women attended 
in the specialized service was characterized by 184 of 
them being from the city of São Paulo (45%), mean age 
of 36 years (SD=12.5), illiterate (191, 46.6%), unemployed 
(221, 54%) and single (217, 53%); who reported following 
a religion (329, 80.1%), who are mothers (311, 75.8%) 
and have unfavorable housing conditions such as home-
less shelters, house squatting/invasion and living on the 
streets (172, 42%). One third of the sample (137, 33%) 
reported having suffered violence during childhood, while 
41% reported suffering violence during adolescence. The 
mean age of the first intercourse was 16 years (SD=3.7), 
and first contact with drugs was at 15 years (SD=7.4).
Among the most prevalent clinical characteristics 
investigated in the medical records, 27 women (6.5%) 
reported having HIV/AIDS, 34 (8.2%) reported Arterial 
Hypertension (AH), and most of them (306, 74.4%) 
reported recurring suicidal ideation.
Regarding the higher prevalence of the behavioral 
profile, 388 women (94.3%) had family members who 
were users of psychoactive substances, of which 42.8% 
used illicit psychoactive substances such as marijuana, 
cocaine or crack. 
With regards to the main psychoactive substance use, 
55% (226) of the women sought treatment for MDI, 148 
(36%) for A (alcohol) and 37 (9%) for MDE. When ana-
lyzing the treatment adherence time, 120 (29%) attended 
the service for up to 1 month, 94 (22.9%) from 1 to 6 
months, 30 (7.3%) from 6 to 12 months, and 101 (24.6%) 
for more than 1 year. 
The results showed a statistically significant associa-
tion between occupation (p<0.000), housing (p=0.003), 
losses in adolescence (p=0.036), having HIV/AIDS 
(p=0.004), having family member users of psychoactive 
substances (p<0.000), and the type of substance used, as 
shown in Table 1. 
The mean age of the participants and their age of first 
sexual intercourse had a statistically significant associa-
tion (p <0.000) with the type of substance used, as shown 
in Table 2. 
Table 1 – Association between the type of substance used and sociodemographic, clinical and behavioral variables – São Paulo, SP, 
Brazil, 2011. 
Variable
Type of substance used
P-valueAlcohol MDE* MDI†
N % N % N %
Occupation       0.026
Employed 18 46.2 40 38.5 33 18.3  
Unemployed 21 53.8 64 61.5 147 81.7  
Housing 0.004
Owned or rented 18 62.1 52 67.5 56 39.4
Homeless shelter/streets 11 37.9 25 32.5 86 60.6
Losses in adolescence      0.036
Yes 7 29.2 44 50.6 61 58.1  
No 17 70.8 43 49.4 44 41.9  
HIV‡ 0.004
Yes 0 0.0 2 2.0 16 11.5
No 35 100.0 96 98.0 123 88.5
Family member substance users     0.001
Alcohol 22 68.8 43 49.4 22 20.6  
Tobacco 0 0.0 5 5.7 8 7.5  
Alcohol and Tobacco 4 12.5 13 14.9 12 11.2  
Illicit substances 6 18.8 26 29.9 65 60.7  
* Multiple drug use excluding cocaine and crack.
† Multiple drug use including cocaine and crack.
‡ Human Immunodeficiency Virus.
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Table 2 – Analysis of variance and multiple comparisons according to the type of substance used and the variables of age and age of 
first sexual intercourse – São Paulo, SP, Brazil, 2011.
Variable N Mean SD
P-value (ANOVA) *
Overall Alcohol MDE† Alcohol MDI‡ MDE MDI‡
Age < 0.001 0.134 < 0.001 < 0.001
Alcohol 47 46.32 9.68
MDE 135 42.90 12.37
MDI 224 30.43 9.50
Age at first intercourse < 0.001 0.076 0.002 0.002
Alcohol 21 19.24 4.82
MDE 84 16.68 3.54
MDI 107 15.02 3.08
* Games-Howell post hoc analysis of variance.
†Multiple drug use excluding cocaine and crack.
‡Multiple drug use including cocaine and crack.
SD: standard deviation
The result of the Ordinal Logistic Regression (Table 3) 
showed a statistically significant relationship between the 
treatment adherence time and the variables: type of sub-
stance used (p=0.013), having family member users of psy-
choactive substances (p=0.014) and having suicidal ideation 
(p<0.000). Table 3 presents the five categories (described 
in the method) and the odds ratio of moving from one 
category to another, in which the greatest predictors for 
this association were: having MDI as the substances used 
(OR=0.22), having family members who use illicit sub-
stances (OR=0.36), and reporting the presence of suicidal 
ideation (OR=2.7).
Table 3 – Relationship between the adherence time in the specialized service and the variables type of substance used, type of sub-
stance used by family members and suicidal ideation – São Paulo, SP, Brazil, 2011.
Variable Category Sig* OR† <95% IC >
Type of substance used Alcohol 1
MD‡ excluding cocaine/crack 0.424 0.644 0.211 1.853
MD including cocaine/crack 0.013 0.224 0.067 0.708
Substances used Alcohol 1
(Family member) Tobacco 0.058 0.286 0.078 1.066
Alcohol and tobacco 0.000 0.164 0.063 0.414
Illicit drugs 0.014 0.360 0.158 0.807
Suicidal ideation Yes 0.004 2.697 1.377 5.320
No 1
* Statistical significance of the Wald test.
† odds ratio.
‡ Multiple drugs.
DISCUSSION
The majority of women who sought a specialized treat-
ment service for psychoactive substance use had a low level of 
education, with a large portion of them reported as being illit-
erate, unemployed and living in precarious housing conditions. 
These variables associated to the use of psychoactive substances 
can aggravate their condition and bring severe repercussions 
to different aspects and stages of life related to the areas of 
health, work, family and social life, as well as psychological 
well-being(7).
These characteristics indicate a vulnerable state, and 
began very early in the lives of these women; most of them 
reported having suffered violence during childhood and 
adolescence, and also starting their sex life and having their 
first contact with drugs at this stage of life. These factors 
may explain a process already described(13), in which certain 
social variables that start early can be reflected or perpetu-
ated in adult life.
Most study participants were MDI users. The higher 
prevalence of users who sought treatment for MDI may be 
related to the characteristics of the study site, since this is 
an area of the city where the concentration of crack users is 
high(14). Moreover, epidemiological studies show a signifi-
cant increase in the consumption of this substance among 
women, even though such use continues to be more preva-
lent among men(9,15).
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Furthermore, in relation to the type of substance used, 
the use of MDI showed an association with the situation of 
unemployment, living in homeless shelters/streets, present-
ing losses in adolescence, having HIV/Aids, having an early 
start of their sexual life and having family member users of 
illicit substances. These variables reflect a lack of access to 
resources and to health and social services for women using 
MDI, placing them in a vulnerable position(16). This find-
ing is consistent with the observations made in a National 
Survey conducted with crack users, which shows the rela-
tionship between vulnerability indicators and the use of 
this substance(17).
These vulnerability conditions may be related to the 
social exclusion of women who use MDI, with restric-
tions on their basic rights. It is also possible that the lack 
of access to resources and social goods result in diverse 
consequences, including to their health due to the exclu-
sion of their formal participation in society; a scenario 
that reproduces the historical social exclusion of psycho-
active substance users(18). Characterizing the social and 
health conditions of the women in this study reinforces a 
necessary focus in the areas recommended by public care 
policies to people with disorders related to psychoactive 
substance use, mainly in the areas related to reintegrating 
users into society, which implies access to work, housing 
and social networks(19). 
In this regard, it must be considered that women who 
use psychoactive substances also face challenges attributed 
to gender issues, which place them in a position of inequal-
ity when compared to men(20). Women who use crack often 
resort to prostitution as a means to getting the drug, and 
as payment they receive little money or the substance itself, 
in addition to not using condoms(21). Other important 
aspects that translate into barriers for the female popula-
tion to begin and remain in treatment are the stigma and 
prejudice they suffer daily because they are seen as crimi-
nals by society, which leads them to abdicate their socially 
constructed role(22).
Women using MDI and those who had family member 
users of illicit substances were more likely to drop out of 
treatment early. Taking into account the aforementioned 
association between the vulnerability experienced by 
women in the MDI group, this factor is probably influ-
enced by the low adherence of these women to treatment. 
The use of illicit substances by family members has been 
pointed out in the literature as a condition for abandon-
ing treatment(23), especially when the person who uses 
psychoactive substances is their partner, who in addition 
to contributing to their addiction by providing money to 
buy the substance, does not offer emotional support to the 
companion(24), leaving them deprived of family support for 
continuing treatment. 
The presence of suicidal ideation was a predictive variable 
for longer treatment adherence time, and women reporting 
this condition had a 2.7-times higher chance of remaining 
in treatment than those who denied such a condition. The 
high prevalence of suicidal ideation found among women 
in this study may be related to the number of women who 
associated MDE and MDI with alcohol, whose depen-
dence has been related to a greater chance of presenting 
suicidal ideation than those who are not dependent on this 
substance(25). Suicidal ideation as a predictor of treatment 
adherence is a fact that has not been found in other pub-
lished studies involving this population, and therefore has 
not aroused research interest until now. Thus, it is considered 
that this finding constitutes a phenomenon of interest for 
future investigations. 
It is believed that these women seek to find a place 
of protection and welcoming in the specialized service, 
which needs to develop intersectoral actions that contem-
plate gender specificity such as: approaches to improve 
their self-esteem, issues related to violence, stigma, feel-
ings of guilt/shame, psychosocial losses, comorbidities, 
and inclusion of their families in order to produce better 
treatment results(26).
In addition, considering the contribution of the findings 
in this study to nursing care, it becomes clear that nurses 
need to be aware of the reality of the demographic and 
epidemiological profile of this clientele in order to plan sin-
gularized actions. Considering the magnitude of the problem 
that psychoactive substance use brings to the lives of the 
investigated women, the vulnerability and social exclusion 
which they are subjected to and which therefore increases 
the risk situations in which they live, we can point out that 
investment in assistance care policies to this population need 
to progress considerably.
The present study presented some limitations that should 
be considered. The implemented questionnaire was elabo-
rated by the health service and applied by different health 
professionals, which leads to several differences regarding its 
completion. A high amount of information was missing in 
the medical records, which were not collected or registered, 
hindering the statistical analysis of some variables.
CONCLUSION
The sociodemographic and epidemiological factors of the 
women in this study are associated with the use of psycho-
active substances, and the developed therapeutic strategies 
must take into account the risk stratification in this group, 
seeking comprehensive and individualized care. Among the 
most important findings, suicidal ideation was a predictor 
for the women remaining in to treatment, and since suicide 
behavior is a phenomenon that is highly stigmatized and 
poorly investigated, implementing screening instruments 
can have significant repercussions on the treatment process. 
It can also be pointed out that a family context permeated 
by psychoactive substance use represents an obstacle to the 
treatment of these women, challenging therapeutic propos-
als to include and strengthen families with the purpose of 
improving treatment adherence.
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RESUMO
Objetivo: Verificar a associação entre o perfil das mulheres que buscaram tratamento especializado para uso de substâncias psicoativas, o 
tempo de permanência no tratamento e os tipos de substância de uso. Método: Coorte retrospectiva realizada com dados de prontuários 
de mulheres que buscaram atendimento em um serviço de referência para uso de substâncias psicoativas. Resultados: A amostra final 
foi de 411 prontuários. Houve associação significativa entre desemprego (p<0,000), morar em rua/albergue (p=0,003) e viver com o 
HIV/Aids (p=0,004) e o tipo de substância de uso. Os maiores preditores do tempo de permanência no tratamento foram ser usuária 
de cocaína e crack (OR=0,22), possuir familiares que fazem uso de substâncias ilícitas (OR= 0,36) e relatar ideação suicida (OR=2,7). 
Conclusão: Os fatores sociodemográficos e epidemiológicos das mulheres deste estudo estão associados ao uso de substâncias psicoativas. 
As estratégias terapêuticas desenvolvidas para esse grupo devem levar em consideração a estratificação de risco, com vistas ao cuidado 
integral e individualizado. Devem-se considerar abordagens persistentes de inclusão da família no tratamento, principalmente daqueles 
familiares que apresentam problemas relacionados ao uso de substâncias psicoativas.
DESCRITORES
Mulheres; Transtornos Relacionados ao Uso de Substâncias; Serviços de Saúde Mental; Centros de Tratamento de Abuso de Substâncias; 
Enfermagem Psiquiátrica.
RESUMEN
Objetivo: Verificar la asociación entre el perfil de las mujeres que buscaron tratamiento especializado para uso de sustancias psicoactivas, 
el tiempo de permanencia en el tratamiento y los tipos de sustancia de uso. Método: Cohorte retrospectiva llevada a cabo con datos de 
fichas de mujeres que buscaron atención en un servicio de referencia para uso de sustancias psicoactivas. Resultados: La muestra final 
fue de 411 fichas. Hubo asociación significativa entre desempleo (p<0,000), vivir en la calle/albergue (p=0,003) y vivir con el VIH/SIDA 
(p=0,004) y el tipo de sustancia de uso. Los mayores predictores del tiempo de permanencia en el tratamiento fueron ser adicto a cocaína 
y crack (OR=0,22), tener familiares que son adictos a sustancias ilícitas (OR= 0,36) y relatar ideación suicida (OR=2,7). Conclusión: 
Los factores sociodemográficos y epidemiológicos de las mujeres de este estudio están asociados con el uso de sustancias psicoactivas. 
Las estrategias terapéuticas desarrolladas para ese grupo deben tener en cuenta la estratificación de riesgo, con vistas al cuidado integral 
e individualizado. Se deben considerar abordajes persistentes de inclusión de la familia en el tratamiento, especialmente de los familiares 
que presentan problemas relacionados con el uso de sustancias psicoactivas.
DESCRIPTORES
Mujeres; Trastornos Relacionados con Uso de Sustancias; Servicios de Salud Mental; Centros de Tratamiento de Abuso de Sustancias; 
Enfermería Psiquiátrica.
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